Net cost of antidiabetic drugs in England 2015/16 Statistic

This statistic displays the Net Ingredient Cost (NIC) of antidiabetic drugs other than biguanides and sulfonylureas in England in 2015/16. In this year, the leading other antidiabetic drug in terms of net ingredient cost was Sitagliptin, costing approximately 93.7 million British pounds.

Net Ingredient Cost (NIC) of antidiabetic drugs (other than biguanides and sulfonylureas) in England in 2015/16 (in 1,000 GBP)

Characteristic	Net Ingredient Cost in thousand GBP
Sitagliptin*	93,690.6
Pioglitazone Hydrochloride*	17,320.7
Linagliptin*	31,389.9
Liraglutide**	47,577.3
Saxagliptin*	12,089.2
Dapagliflozin*	23,312.8
Exenatide	19,362.4
Vildagliptin*	5,219.1
Repaglinide	626.7
Lixisenatide	5,792.9
Acarbose	523.8
Canagliflozin*	7,944.6
Alogliptin*	4,772.7
Nateglinide	355.1
Empagliflozin*	1,900.9
Dulaglutide	693.5
Rosiglitazone*	0.2

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

August 2016

More information

Region

United Kingdom (England)

Survey time period

April 2005 to March 2016

Supplementary notes

* includes combination with metformin.
** includes combination with insulin degludec.

The source also adds the following information: 'Please note where drugs are shown to include combinations with metformin this is only where a combination product containing both drugs has been prescribed. There is no information on whether the combination of metformin and another Other antidiabetic drug is prescribed separately as patient information is not captured within the dataset.'
This statistic is using original data from the Health and Social Care Information Centre and includes copyright material from © Crown, licensed under the Open Government License v3.0

Citation formats